Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy
Ptushkin, V V, Kulagin, A D, Lukina, E A, Davydkin, I L, Konstantinova, T S, Shamrai, V S, Minaeva, N V, Kudlay, D A, Gapchenko, E V, Markova, O A, Borozinets, A Y
Published in Terapevtic̆eskii arhiv (01.09.2020)
Published in Terapevtic̆eskii arhiv (01.09.2020)
Get full text
Journal Article
THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
Tereshchenko, S. N., Chuich, N. G., Syrkin, A. L., Andreev, D. A., Kolchurina, A. V., Terentev, V. P., Borozinets, A. Yu
Published in Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii (01.01.2010)
Published in Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii (01.01.2010)
Get full text
Journal Article